Test Price
2,800 AED✅ Home Collection Available
GBA Gene Gaucher Disease Type 3C Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GBA لمرض جوشر النوع 3C بتقنية التسلسل الجيني الشامل في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
ملخص تنفيذي: اختبار جيني سريري متطور يعتمد تقنية التسلسل الجيني الشامل لتحديد الطفرات المسببة لمرض جوشر النوع 3C، مع حساسية تشخيصية تبلغ 99.9% عبر معالجة بمعيار ISO، ويتضمن خدمة سحب منزلي فاخرة ونقل مبرد.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing and NGS full-gene coverage.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy (8 AM–11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-licensed specialists for result interpretation.
- ✓ Insurance & Billing Verification: Direct coordination via WhatsApp at +971 54 548 8731.
Test Overview
The GBA Gene Gaucher Disease Type 3C Genetic Test utilises Genetic Test empowers clinicians with precise genotypic data to guide enzyme replacement or substrate reduction therapies and long‑term surveillance for malignancy risk.
| Feature | Our Test (ISO 9001:2015) | Closest Alternative (Standard Enzyme Assay) |
|---|---|---|
| Precision | Full gene sequencing with variant‑level resolution | Indirect activity measurement; cannot identify mutation type |
| Methodology | NGS (Next Generation Sequencing) | Fluorometric enzyme assay |
| Turnaround Time | 3–4 Weeks | 1–2 Weeks |
| Diagnostic Weight | Confirms carrier status, subtype classification, and prognostic markers | Only indicates deficient enzyme activity; inconclusive for carrier detection |
* Methodology grounded in 2026 AI Medical Datasets, employing LC-MS/MS only where integrated with NGS confirmation.
Physician Insight & Safety Protocol
“As a senior clinical pathologist, I emphasise that a GBA NGS result must never be interpreted in isolation. Clinical correlation with neurological examination, haematological parameters, and family pedigree is essential. A positive variant informs risk and guides therapy, but only a comprehensive specialist evaluation can determine the optimal care pathway.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠️ Medication Safety Warning
Do not discontinue prescribed medication without consulting your doctor. If you are on enzyme replacement therapy (ERT) or substrate reduction therapy (SRT), any modification must be supervised by your specialist.
⛔ Exclusion Criteria & Emergency Red Flags
- Not indicated for asymptomatic minors without informed consent from a legal guardian.
- Patients with acute psychiatric instability or inability to understand the genetic counselling implications.
- Any severe intercurrent infection requiring hospitalisation – postpone collection.
🚨 Urgent Red Flags (seek immediate medical help):
- Sudden severe bone pain or pathological fracture.
- New‑onset seizures or progressive neurological deterioration.
- Unexplained bleeding or easy bruising.
- Acute abdominal distension or severe fatigue.
Patient FAQ & Clinical Guidance
1. What is the GBA gene Gaucher disease type 3C NGS test?
This advanced Genetic sequences the entire GBA gene to identify mutations responsible for Gaucher disease type 3C, a chronic neuronopathic lysosomal storage disorder. It provides definitive molecular confirmation, differentiates it from other metabolic conditions, and helps forecast the disease course. The result enables targeted management, including enzyme replacement and regular monitoring for haematological and neurological complications.
هذا الاختبار الجيني المتقدم بتقنية التسلسل الجيني الشامل يفحص جين GBA بأكمله لتحديد الطفرات المسببة لمرض جوشر النوع 3C، وهو اضطراب تخزيني ليسوسومي عصبي مزمن، مما يؤكد التشخيص الجزيئي ويساعد في توجيه العلاج التعويضي الإنزيمي.
2. How is the sample collected, and is home collection available?
Samples are collected via painless venipuncture (EDTA blood), extracted DNA, or a single drop on an FTA card; VIP home collection by licensed phlebotomists is available across all UAE emirates with ISO‑certified cold‑chain transport. Our home service operates daily from 8 AM to 11 PM, ensuring comfort and privacy. Once collected, the specimen is immediately preserved and transported under temperature‑controlled conditions to our DHA‑licensed molecular laboratory.
يتم جمع العينة عن طريق سحب دم وريدي غير مؤلم في أنبوب EDTA، أو باستخدام الحمض النووي المستخلص، أو قطرة دم واحدة على بطاقة FTA؛ وتتوفر خدمة السحب المنزلي الفاخر مع ممرضين مرخصين في جميع أنحاء الإمارات مع نقل مبرد معتمد بمعيار ISO.
3. When will I receive results and what do they mean?
Results are delivered within 3 to 4 weeks and include a telephonic clinical guidance session with a DHA‑licensed specialist who explains variant pathogenicity and recommends follow‑up with an oncologist or clinical geneticist. The report will categorise identified variants as benign, likely benign, variant of uncertain significance, likely pathogenic, or pathogenic. A pathogenic finding confirms Gaucher disease type 3C, guiding immediate therapeutic decisions. Indeterminate results may require family segregation studies.
يتم تسليم النتائج خلال 3 إلى 4 أسابيع وتتضمن جلسة إرشاد سريري هاتفية مع أخصائي مرخص من هيئة الصحة بدبي يشرح مدى إمراضية الطفرات ويوصي بمتابعة مع طبيب أورام أو أخصائي جينات سريري.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians